Sharechat Logo

TruScreen strengthens its market presence in central and eastern Europe

Wednesday 5th August 2020

Text too small?

As part of the rationalisation of its distributors network, Truscreen Limited (NZX: TRU ) (“the Company”) is pleased to announce that it has appointed prominent medical device distributor Aspironix, s.r.o (Aspironix) as its exclusive distributor for Czech Republic, Slovakia, and Poland.

The territories of Czech Republic, Slovakia, and Poland, have a combined cervical cancer addressable screening population of over 17.91 million women, presenting a significant market opportunity for the Company.

Asprionix is a well-established specialised medical device distributor based in Prague, with a rapidly growing turnover and increasing presence in central and eastern Europe.

Together with Aspironix, the Company will develop a comprehensive market access plan and have begun preliminary Key Opinion Leaders (KOL) engagement for the region.

Truscreen CEO, Victoria Potarina, said “The distribution agreement with Aspironix will enable us to significantly expand our distribution capabilities in central and eastern Europe, bringing Truscreen’s latest real-time cervical cancer screening technology to the women of Czech Republic, Slovakia and Poland.

The rationalisation of our distributor portfolio will see established and committed medical device distributors, like Aspironix partnering with Truscreen to bring our Truscreen cervical cancer screening technology to the millions of women who are currently not covered by effective cervical cancer screening.”

Source: TruScreen 



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Synlait Milk Limited (NZX: SML) Sustainability Report Shows GHG Emissions Improvements
IPO Offer: New Zealand Rural Land Co
Infratil Limited 6-year Infrastructure Bonds
Allied Farmers Limited (NZX: ALF) Launch of Renounceable Rights Issue
NZ Windfarms Limited (NZX: NWF) VVFPA Document Completion and FY2021 EBITDAF Guidance Range
Property for Industry Limited (NZX: PFI) Signals Positive Valuation Outcome
SkyCity Entertainment Group Limited (NZX: SKC) Update on SkyCity Adelaide, Including Opening of Expansion
Sky Network Television Limited (NZX: SKT) Announces Chief Executive Change
Evolve Education Group Limited (NZX: EVO) Share Consolidation
IPO Offer: New Zealand Rural Land Co

IRG See IRG research reports